Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perimentase in adult T-cell lymphoma
ChiCTR1800016940Phase 4Recruiting
- Sponsor
- Peking University Cancer Hospital & Institute
- Start
- Jan 2012
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of pegaspargase in T-cell lymphoma, natural killer/T-cell lymphoma (NKTL) and T-lymphoblastic lymphoma (T-LBL) (2 arms), sponsored by Peking University Cancer Hospital & Institute. Primary endpoints: overall response rate, complete remission rate and 1 more. Started Jan 2012; status: recruiting.
02
Drugs
pegaspargase
03
Conditions
T-cell lymphomanatural killer/T-cell lymphoma (NKTL)T-lymphoblastic lymphoma (T-LBL)
Beyond the preview
Go deeper on ChiCTR1800016940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800016940.